Skip to main content
Erschienen in: Critical Care 1/2015

01.12.2015 | Review

Angiotensin II in septic shock

verfasst von: Thiago D Corrêa, Jukka Takala, Stephan M Jakob

Erschienen in: Critical Care | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2015 and co-published as a series in Critical Care. Other articles in the series can be found online at http://​ccforum.​com/​series/​annualupdate2015​. Further information about the Annual Update in Intensive Care and Emergency Medicine is available from http://​www.​springer.​com/​series/​8901.
Literatur
1.
Zurück zum Zitat Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2012;41:580–637.CrossRef Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2012;41:580–637.CrossRef
2.
Zurück zum Zitat Dunser MW, Ruokonen E, Pettila V, et al. Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial. Crit Care. 2009;13:R181.PubMedPubMedCentralCrossRef Dunser MW, Ruokonen E, Pettila V, et al. Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial. Crit Care. 2009;13:R181.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat De Backer D, Aldecoa C, Njimi H, Vincent JL. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med. 2012;40:725–30.PubMedCrossRef De Backer D, Aldecoa C, Njimi H, Vincent JL. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med. 2012;40:725–30.PubMedCrossRef
4.
Zurück zum Zitat Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877–87.PubMedCrossRef Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877–87.PubMedCrossRef
6.
Zurück zum Zitat Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol. 2003;35:881–900.PubMedCrossRef Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol. 2003;35:881–900.PubMedCrossRef
7.
Zurück zum Zitat Correa TD, Jeger V, Pereira AJ, Takala J, Djafarzadeh S, Jakob SM. Angiotensin II in septic shock: effects on tissue perfusion, organ function, and mitochondrial respiration in a porcine model of fecal peritonitis. Crit Care Med. 2014;42:e550–9.PubMedCrossRef Correa TD, Jeger V, Pereira AJ, Takala J, Djafarzadeh S, Jakob SM. Angiotensin II in septic shock: effects on tissue perfusion, organ function, and mitochondrial respiration in a porcine model of fecal peritonitis. Crit Care Med. 2014;42:e550–9.PubMedCrossRef
8.
Zurück zum Zitat Paul M, Poyan MA, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86:747–803.PubMedCrossRef Paul M, Poyan MA, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86:747–803.PubMedCrossRef
9.
Zurück zum Zitat Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ Res. 2000;87:E1–9.PubMedCrossRef Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ Res. 2000;87:E1–9.PubMedCrossRef
10.
Zurück zum Zitat Santos RA, Ferreira AJ. Angiotensin-(1–7) and the renin-angiotensin system. Curr Opin Nephrol Hypertens. 2007;16:122–8.PubMedCrossRef Santos RA, Ferreira AJ. Angiotensin-(1–7) and the renin-angiotensin system. Curr Opin Nephrol Hypertens. 2007;16:122–8.PubMedCrossRef
11.
Zurück zum Zitat Zhuo JL, Li XC. New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II. Peptides. 2011;32:1551–65.PubMedPubMedCentralCrossRef Zhuo JL, Li XC. New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II. Peptides. 2011;32:1551–65.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Sasamura H, Hein L, Krieger JE, Pratt RE, Kobilka BK, Dzau VJ. Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem Biophys Res Commun. 1992;185:253–9.PubMedCrossRef Sasamura H, Hein L, Krieger JE, Pratt RE, Kobilka BK, Dzau VJ. Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem Biophys Res Commun. 1992;185:253–9.PubMedCrossRef
13.
Zurück zum Zitat Iwai N, Inagami T. Identification of two subtypes in the rat type I angiotensin II receptor. FEBS Lett. 1992;298:257–60.PubMedCrossRef Iwai N, Inagami T. Identification of two subtypes in the rat type I angiotensin II receptor. FEBS Lett. 1992;298:257–60.PubMedCrossRef
14.
Zurück zum Zitat Lavoie JL, Sigmund CD. Minireview: overview of the renin-angiotensin system – an endocrine and paracrine system. Endocrinology. 2003;144:2179–83.PubMedCrossRef Lavoie JL, Sigmund CD. Minireview: overview of the renin-angiotensin system – an endocrine and paracrine system. Endocrinology. 2003;144:2179–83.PubMedCrossRef
15.
Zurück zum Zitat Larkin JE, Frank BC, Gaspard RM, Duka I, Gavras H, Quackenbush J. Cardiac transcriptional response to acute and chronic angiotensin II treatments. Physiol Genomics. 2004;18:152–66.PubMedCrossRef Larkin JE, Frank BC, Gaspard RM, Duka I, Gavras H, Quackenbush J. Cardiac transcriptional response to acute and chronic angiotensin II treatments. Physiol Genomics. 2004;18:152–66.PubMedCrossRef
16.
17.
Zurück zum Zitat Schaller MD, Waeber B, Nussberger J, Brunner HR. Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia. Am J Physiol. 1985;249:H1086–92.PubMed Schaller MD, Waeber B, Nussberger J, Brunner HR. Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia. Am J Physiol. 1985;249:H1086–92.PubMed
18.
Zurück zum Zitat Tamion F, Le Cam-Duchez V, Menard JF, Girault C, Coquerel A, Bonmarchand G. Erythropoietin and renin as biological markers in critically ill patients. Crit Care. 2004;R328–R335 Tamion F, Le Cam-Duchez V, Menard JF, Girault C, Coquerel A, Bonmarchand G. Erythropoietin and renin as biological markers in critically ill patients. Crit Care. 2004;R328–R335
19.
Zurück zum Zitat Doerschug KC, Delsing AS, Schmidt GA, Ashare A. Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis. Crit Care. 2010;14:R24.PubMedPubMedCentralCrossRef Doerschug KC, Delsing AS, Schmidt GA, Ashare A. Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis. Crit Care. 2010;14:R24.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Hilgenfeldt U, Kienapfel G, Kellermann W, Schott R, Schmidt M. Renin-angiotensin system in sepsis. Clin Exp Hypertens A. 1987;9:1493–504.PubMed Hilgenfeldt U, Kienapfel G, Kellermann W, Schott R, Schmidt M. Renin-angiotensin system in sepsis. Clin Exp Hypertens A. 1987;9:1493–504.PubMed
21.
Zurück zum Zitat Bucher M, Ittner KP, Hobbhahn J, Taeger K, Kurtz A. Downregulation of angiotensin II type 1 receptors during sepsis. Hypertension. 2001;38:177–82.PubMedCrossRef Bucher M, Ittner KP, Hobbhahn J, Taeger K, Kurtz A. Downregulation of angiotensin II type 1 receptors during sepsis. Hypertension. 2001;38:177–82.PubMedCrossRef
22.
Zurück zum Zitat Bucher M, Hobbhahn J, Kurtz A. Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis. Crit Care Med. 2001;29:1750–5.PubMedCrossRef Bucher M, Hobbhahn J, Kurtz A. Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis. Crit Care Med. 2001;29:1750–5.PubMedCrossRef
23.
Zurück zum Zitat Mederle K, Schweda F, Kattler V, et al. The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotension. Crit Care. 2013;17:R130.PubMedPubMedCentralCrossRef Mederle K, Schweda F, Kattler V, et al. The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotension. Crit Care. 2013;17:R130.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Lund DD, Brooks RM, Faraci FM, Heistad DD. Role of angiotensin II in endothelial dysfunction induced by lipopolysaccharide in mice. Am J Physiol Heart Circ Physiol. 2007;293:H3726–31.PubMedCrossRef Lund DD, Brooks RM, Faraci FM, Heistad DD. Role of angiotensin II in endothelial dysfunction induced by lipopolysaccharide in mice. Am J Physiol Heart Circ Physiol. 2007;293:H3726–31.PubMedCrossRef
26.
Zurück zum Zitat Klein N, Gembardt F, Supe S, et al. Angiotensin-(1–7) protects from experimental acute lung injury. Crit Care Med. 2013;41:e334–43.PubMedCrossRef Klein N, Gembardt F, Supe S, et al. Angiotensin-(1–7) protects from experimental acute lung injury. Crit Care Med. 2013;41:e334–43.PubMedCrossRef
28.
Zurück zum Zitat May CN, Ishikawa K, Wan L, et al. Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion. Intensive Care Med. 2012;38:886–93.PubMedCrossRef May CN, Ishikawa K, Wan L, et al. Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion. Intensive Care Med. 2012;38:886–93.PubMedCrossRef
29.
Zurück zum Zitat Salgado DR, Rocco JR, Silva E, Vincent JL. Modulation of the renin-angiotensin-aldosterone system in sepsis: a new therapeutic approach? Expert Opin Ther Targets. 2010;14:11–20.PubMedCrossRef Salgado DR, Rocco JR, Silva E, Vincent JL. Modulation of the renin-angiotensin-aldosterone system in sepsis: a new therapeutic approach? Expert Opin Ther Targets. 2010;14:11–20.PubMedCrossRef
30.
Zurück zum Zitat Correa TD, Vuda M, Blaser AR, et al. Effect of treatment delay on disease severity and need for resuscitation in porcine fecal peritonitis. Crit Care Med. 2012;40:2841–9.PubMedCrossRef Correa TD, Vuda M, Blaser AR, et al. Effect of treatment delay on disease severity and need for resuscitation in porcine fecal peritonitis. Crit Care Med. 2012;40:2841–9.PubMedCrossRef
31.
Zurück zum Zitat Cuesta JM, Singer M. The stress response and critical illness: a review. Crit Care Med. 2012;40:3283–9.PubMedCrossRef Cuesta JM, Singer M. The stress response and critical illness: a review. Crit Care Med. 2012;40:3283–9.PubMedCrossRef
32.
Zurück zum Zitat Rolih CA, Ober KP. The endocrine response to critical illness. Med Clin North Am. 1995;79:211–24.PubMedCrossRef Rolih CA, Ober KP. The endocrine response to critical illness. Med Clin North Am. 1995;79:211–24.PubMedCrossRef
33.
Zurück zum Zitat du Cheyron D, Lesage A, Daubin C, Ramakers M, Charbonneau P. Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure. Intensive Care Med. 2003;29:1703–9.PubMedCrossRef du Cheyron D, Lesage A, Daubin C, Ramakers M, Charbonneau P. Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure. Intensive Care Med. 2003;29:1703–9.PubMedCrossRef
34.
Zurück zum Zitat Thomas VL, Nielsen MS. Administration of angiotensin II in refractory septic shock. Crit Care Med. 1991;19:1084–6.PubMedCrossRef Thomas VL, Nielsen MS. Administration of angiotensin II in refractory septic shock. Crit Care Med. 1991;19:1084–6.PubMedCrossRef
35.
Zurück zum Zitat Wray GM, Coakley JH. Severe septic shock unresponsive to noradrenaline. Lancet. 1995;346:1604.PubMedCrossRef Wray GM, Coakley JH. Severe septic shock unresponsive to noradrenaline. Lancet. 1995;346:1604.PubMedCrossRef
37.
Zurück zum Zitat Denton KM, Anderson WP, Sinniah R. Effects of angiotensin II on regional afferent and efferent arteriole dimensions and the glomerular pole. Am J Physiol Regul Integr Comp Physiol. 2000;279:R629–38.PubMedCrossRef Denton KM, Anderson WP, Sinniah R. Effects of angiotensin II on regional afferent and efferent arteriole dimensions and the glomerular pole. Am J Physiol Regul Integr Comp Physiol. 2000;279:R629–38.PubMedCrossRef
38.
Zurück zum Zitat Pereira AJ, Jeger V, Fahrner R, et al. Interference of angiotensin II and enalapril with hepatic blood flow regulation. Am J Physiol Gastrointest Liver Physiol. 2014;307:G655–663.PubMedCrossRef Pereira AJ, Jeger V, Fahrner R, et al. Interference of angiotensin II and enalapril with hepatic blood flow regulation. Am J Physiol Gastrointest Liver Physiol. 2014;307:G655–663.PubMedCrossRef
39.
Zurück zum Zitat Yu HP, Hsu JC, Yen CH, Ma YH, Lau YT. Hyporeactivity of renal artery to angiotensin II in septic rats. Chin J Physiol. 2008;51:301–7.PubMed Yu HP, Hsu JC, Yen CH, Ma YH, Lau YT. Hyporeactivity of renal artery to angiotensin II in septic rats. Chin J Physiol. 2008;51:301–7.PubMed
40.
Zurück zum Zitat Jeger V, Djafarzadeh S, Jakob SM, Takala J. Mitochondrial function in sepsis. Eur J Clin Invest. 2013;43:532–42.PubMedCrossRef Jeger V, Djafarzadeh S, Jakob SM, Takala J. Mitochondrial function in sepsis. Eur J Clin Invest. 2013;43:532–42.PubMedCrossRef
41.
Zurück zum Zitat Kimura S, Zhang GX, Nishiyama A, et al. Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide. Hypertension. 2005;45:438–44.PubMedCrossRef Kimura S, Zhang GX, Nishiyama A, et al. Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide. Hypertension. 2005;45:438–44.PubMedCrossRef
42.
Zurück zum Zitat Robertson Jr AL, Khairallah PA. Angiotensin II: rapid localization in nuclei of smooth and cardiac muscle. Science. 1971;172:1138–9.PubMedCrossRef Robertson Jr AL, Khairallah PA. Angiotensin II: rapid localization in nuclei of smooth and cardiac muscle. Science. 1971;172:1138–9.PubMedCrossRef
43.
Zurück zum Zitat Sirett NE, McLean AS, Bray JJ, Hubbard JI. Distribution of angiotensin II receptors in rat brain. Brain Res. 1977;122:299–312.PubMedCrossRef Sirett NE, McLean AS, Bray JJ, Hubbard JI. Distribution of angiotensin II receptors in rat brain. Brain Res. 1977;122:299–312.PubMedCrossRef
44.
Zurück zum Zitat Peters J, Kranzlin B, Schaeffer S, et al. Presence of renin within intramitochondrial dense bodies of the rat adrenal cortex. Am J Physiol. 1996;271:E439–50.PubMed Peters J, Kranzlin B, Schaeffer S, et al. Presence of renin within intramitochondrial dense bodies of the rat adrenal cortex. Am J Physiol. 1996;271:E439–50.PubMed
45.
Zurück zum Zitat Wanka H, Kessler N, Ellmer J, et al. Cytosolic renin is targeted to mitochondria and induces apoptosis in H9c2 rat cardiomyoblasts. J Cell Mol Med. 2009;13:2926–37.PubMedCrossRef Wanka H, Kessler N, Ellmer J, et al. Cytosolic renin is targeted to mitochondria and induces apoptosis in H9c2 rat cardiomyoblasts. J Cell Mol Med. 2009;13:2926–37.PubMedCrossRef
46.
Metadaten
Titel
Angiotensin II in septic shock
verfasst von
Thiago D Corrêa
Jukka Takala
Stephan M Jakob
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 1/2015
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-015-0802-3

Weitere Artikel der Ausgabe 1/2015

Critical Care 1/2015 Zur Ausgabe

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.